NMN supplement for immune recovery in HIV patients
Part of Immune system & allergy, Infections clinical trials.
This study tests whether a daily NMN supplement can help improve immune recovery (CD4 count) in people with HIV who have low CD4 despite successful viral control. It may help those who have not regained enough immune cells after years of antiretroviral therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and living with HIV.
- Your viral load must be undetectable (below 200 copies/mL) on at least two tests taken 6 months apart.
- Your CD4 count must be below 350 for at least 2 years, even though you are on effective HIV treatment.
- You cannot have active infections, certain medical conditions, or be pregnant or breastfeeding.
- You cannot currently take niacin, nicotinamide riboside, or other supplements that affect NAD+ levels.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a sustained-release nicotinamide mononucleotide (NMN) supplement can improve immune aging and metabolism in people aged 50-70 who are overweight or have fatty liver, pre-diabetes, or mild type 2 diabetes.
This study looks at how the body uses NAD+ precursors (nutrients that help cells produce energy) after taking them by mouth. Healthy volunteers will help researchers understand how these supplements are processed, which may guide future treatments for aging and disease.
This trial tests whether a supplement called NMN is safe and well-tolerated in children and adults with a rare genetic condition called DHDDS-CDG. NMN may help support cellular energy and protein production, which are affected by this condition.
This trial tests whether a supplement called nicotinamide mononucleotide (NMN) can help healthy adults aged 60 to 80 improve their exercise tolerance. You'll take the supplement and do supervised cycling sessions to see if it boosts your stamina.
This study tests new treatments to help people with HIV who have low CD4 counts despite antiretroviral therapy. It aims to improve immune function and reduce the risk of infections.
This study tests if nicotinamide mononucleotide (NMN), a natural supplement, can help middle-aged and older adults stay healthy. It aims to see if NMN can slow aging-related changes in healthy people between 40-70 years old.
Hear when a new Human Immunodeficiency Virus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.